Drug Therapy, Combination
"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy with two or more separate preparations given for a combined effect.
| Descriptor ID |
D004359
|
| MeSH Number(s) |
E02.319.310
|
| Concept/Terms |
Drug Therapy, Combination- Drug Therapy, Combination
- Combination Chemotherapy
- Drug Polytherapy
- Drug Polytherapies
- Polytherapies, Drug
- Polytherapy, Drug
- Therapy, Combination Drug
- Chemotherapy, Combination
- Chemotherapies, Combination
- Combination Chemotherapies
- Combination Drug Therapy
- Combination Drug Therapies
- Drug Therapies, Combination
- Therapies, Combination Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".
Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".
This graph shows the total number of publications written about "Drug Therapy, Combination" by people in this website by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 20 | 22 |
| 1997 | 0 | 13 | 13 |
| 1998 | 0 | 12 | 12 |
| 1999 | 0 | 20 | 20 |
| 2000 | 1 | 8 | 9 |
| 2001 | 0 | 16 | 16 |
| 2002 | 0 | 19 | 19 |
| 2003 | 0 | 22 | 22 |
| 2004 | 1 | 16 | 17 |
| 2005 | 0 | 22 | 22 |
| 2006 | 0 | 20 | 20 |
| 2007 | 0 | 26 | 26 |
| 2008 | 1 | 25 | 26 |
| 2009 | 1 | 25 | 26 |
| 2010 | 0 | 28 | 28 |
| 2011 | 0 | 23 | 23 |
| 2012 | 2 | 11 | 13 |
| 2013 | 1 | 28 | 29 |
| 2014 | 1 | 23 | 24 |
| 2015 | 0 | 21 | 21 |
| 2016 | 0 | 13 | 13 |
| 2017 | 0 | 16 | 16 |
| 2018 | 2 | 21 | 23 |
| 2019 | 0 | 23 | 23 |
| 2020 | 2 | 16 | 18 |
| 2021 | 1 | 16 | 17 |
| 2022 | 0 | 10 | 10 |
| 2023 | 0 | 9 | 9 |
| 2024 | 1 | 7 | 8 |
| 2025 | 0 | 17 | 17 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.
-
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial. JAMA Dermatol. 2026 07 01; 162(7):709-719.
-
Combining Guselkumab with Upadacitinib Is Safe and Effective in the Treatment of Medically Complex Inflammatory Bowel Disease. Dig Dis Sci. 2026 Oct; 71(10):4831-4841.
-
Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies. Inflamm Bowel Dis. 2025 Oct 01; 31(10):2714-2724.
-
Efficacy and tolerability of fenfluramine with concomitant potassium bromide in patients with Dravet syndrome. Epilepsia Open. 2025 Oct; 10(5):1323-1333.
-
Triple therapy vs dual inhaler therapy for moderate-to-severe asthma: An updated systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2025 09; 135(3):278-286.e11.
-
Therapeutic Choices in Systemic Sclerosis-Associated Interstitial Lung Disease, a Survey of 2 International Research Groups. J Clin Rheumatol. 2025 Oct 01; 31(7):284-287.
-
Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet. 2025 05 17; 405(10491):1757-1768.
-
Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2. Fertil Steril. 2025 Sep; 124(3):523-533.
-
Impact of Batoclimab Treatment on LDL-C with and Without Coadministration of Atorvastatin: Results from a Phase I Randomized Study in Healthy Participants. Drug Saf. 2025 Sep; 48(9):993-1004.
-
GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series. BMJ Open Diabetes Res Care. 2025 Apr 23; 13(2).